Company / Free Cash Flow per Share
Amylyx Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.12
FY2025
5-year range
-$25.98 / $0.16
FY2021-FY2025
Trend
+54.0%
vs FY2024
Sector context
#107 of 192
Health Care
What the data says
At $-1.12, Amylyx Pharmaceuticals, Inc.'s free cash flow per share ranks #107 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 5 years, ranging from $-25.98 in FY2022 to $0.16 in FY2023.
Based on SEC 10-K filings.
-1.12 in FY2025.
Declined from $0.16 to $-1.12 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 192 in Health CareTop 56% of 192This company -$1.12 Sector average -$19.84
▼
+94.3% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 54.0% year-over-year.
- Ranks #107 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.12 | +54.0% |
| FY2024 | -$2.45 | -1650.4% |
| FY2023 | $0.16 | +100.6% |
| FY2022 | -$25.98 | -127.7% |
| FY2021 | -$11.41 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026